Literature DB >> 6767794

Effect of viral infections on pulmonary function in patients with chronic obstructive pulmonary diseases.

C B Smith, R E Kanner, C A Golden, M R Klauber, A D Renzetti.   

Abstract

The effect of 100 separate viral infections of the respiratory tract on pulmonary function was evaluated prospectively over an eight-year period in 84 patients with chronic obstructive pulmonary diseases and in eight normal subjects. Some viral infections were associated with small acute declines in forced vital capacity and/or 1-sec forced expiratory volume of 25-300 ml. These declines were detectable only during the 90-day period after infection. The greatest abnormalities of pulmonary function followed infections with influenza virus, and the mean acute changes in 1-sec forced expiratory volume (-118.5 ml) were significantly greater than expected (-15.2 ml; P = 0.03). Smaller, statistically insignificant declines followed infections with parainfluenza virus, rhinovirus, adenovirus, and respiratory syncytial virus, and no changes were detectable after infections with coronavirus, herpes simplex virus, Mycoplasma pneumoniae, and Haemophilus influenzae. Long-term effects of influenza or other viral infections on the course of chronic obstructive pulmonary disease were not detected in this study population.

Entities:  

Mesh:

Year:  1980        PMID: 6767794      PMCID: PMC7109891          DOI: 10.1093/infdis/141.3.271

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

Review 1.  Chronic airway disease: the infection connection.

Authors:  S B Greenberg; R L Atmar
Journal:  Trans Am Clin Climatol Assoc       Date:  1999

2.  Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the Ciba symposium.

Authors:  C M Fletcher; N B Pride
Journal:  Thorax       Date:  1984-02       Impact factor: 9.139

3.  Pneumocystis infection alters the activation state of pulmonary macrophages.

Authors:  Jessica M Deckman; Cathryn J Kurkjian; Joseph P McGillis; Theodore J Cory; Susan E Birket; Linda M Schutzman; Brian S Murphy; Beth A Garvy; David J Feola
Journal:  Immunobiology       Date:  2016-10-05       Impact factor: 3.144

Review 4.  Insights into the interaction between influenza virus and pneumococcus.

Authors:  Jonathan A McCullers
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

Review 5.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.

Authors:  G J Gorse; R B Belshe; N J Munn
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

Review 7.  Chronic obstructive pulmonary disease . 6: The aetiology of exacerbations of chronic obstructive pulmonary disease.

Authors:  A J White; S Gompertz; R A Stockley
Journal:  Thorax       Date:  2003-01       Impact factor: 9.139

8.  Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines.

Authors:  G J Gorse; R B Belshe; N J Munn
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

9.  Vagal and sympathetic heart rate and blood pressure control in adult onset PHOX2B mutation-confirmed congenital central hypoventilation syndrome.

Authors:  André Diedrich; Beth A Malow; Nick A Antic; Kyoko Sato; R Doug McEvoy; Christopher J Mathias; David Robertson; Elizabeth M Berry-Kravis; Debra E Weese-Mayer
Journal:  Clin Auton Res       Date:  2007-05-31       Impact factor: 4.435

10.  Two different dosages of ciprofloxacin in patients with respiratory tract infections.

Authors:  T Brutel de la Rivière; M S Daniëls-Bosman; G P ten Velde
Journal:  Pharm Weekbl Sci       Date:  1989-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.